What About Pharmacologic Therapy?

Learning about oxytocin: pharmacologic and behavioral issues.

Despite the accumulating evidence suggesting that the neuropeptide oxytocin (OT) plays a role in neuropsychiatric disorders characterized by social dysfunction, the influence of OT on the nonsocial aspects of learning and memory have been less investigated. To foster research in this area, we review the effects of OT on learning and memory in animal models and humans. In healthy animal models, ...

Pharmacologic therapy for acute pain.

The approach to patients with acute pain begins by identifying the underlying cause and a disease-specific treatment. The first-line pharmacologic agent for the symptomatic treatment of mild to moderate pain is acetaminophen or a nonsteroidal anti-inflammatory drug (NSAID). The choice between these two medications depends on the type of pain and patient risk factors for NSAID-related adverse ef...

What about add-on second-line controller therapy?

(VEGF) levels in our study. The lowest and highest levels that we observed were 202 pg/mL and 1,538 pg/mL, respectively. We have five patients with VEGF levels 1,000 pg/mL. All of these patients have bilateral infiltration in their chest radiographs. A significant correlation (p 0.05) was observed between VEGF levels and fever in active pulmonary tuberculosis patients. However, there was not an...

What about Memory, Consciousness, Recall, and Awareness in Anesthesia?

Regression of aortic aneurysms through pharmacologic therapy?

“There is no disease more conducive to clinical humility than aneurysm of the aorta.” These words of Sir William Osler still resonate today, when many patients with ruptured abdominal aortic aneurysms die before reaching the hospital and the mortality rate among those who reach the hospital can exceed 50 percent. The prevention of rupture through early detection and elective repair remains the ...